CTRI/2020/12/030046尚未招募未知
safety of Remdesivir use in patients with acute or chronic kidney disease and covid 19 infection
DrMaulin Shah0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All covid positive (Rapid antigen test or RT PCR) patients admitted in shree Krishna hospital from March 2020 whose presenting creatinine is more than 1.4 mg/dl in Male or 1.2 mg/dl in Female or who are having oliguria /anuria (urine output less than 0.5 ml/kg/hour in first 24 hours -as per Standard KDIGO criteria) and who also received Remdesivir short or prolonged course during hospital stay will be included.
排除标准
- •Those Covid positive patients with renal dysfunction will be excluded from study if they do not complete the course of remdesevir suggested by clinician.
- •However, those patients who expired during treatment of remdesivir will be included in study and they will be analyzed separately.
研究者
相似试验
招募中
3 期
Assessment of utility of Remdesivir in Patients with Acute Kidney Injury or Cronic Kidney Disease in admitted COVID-19 patientsCondition 1: COVID-19. Condition 2: Acute Kidney Injury. Condition 3: Chronic Kidney Disease.Coronavirus infection, unspecifiedAcute kidney failureChronic kidney disease (CKD)B34.2IRCT20210709051824N1Men's Health and Reproductive Health Research Center(MHRHRC)100
招募中
2 期
Evaluating the effects of remdesivir in severe COVID-19 in hospitalized patientsIRCT20151227025726N28Shahid Beheshti University of Medical Sciences120
尚未招募
不适用
To study whether Remdesivir (an antiviral, used for the treatment of COVID - 19) is effective in COVID 19 patients with respect to complications of the disease or death.CTRI/2021/01/030385Kasturba Medical College Manipal
尚未招募
不适用
To Study the safety of Remdesivir in COVID-19 Patients.CTRI/2020/10/028487AIIMS Patna
招募中
3 期
Efficacy of Remdesivir in Comparison with Interferon Beta-1 a and Remdesivir in the Treatment of Covid 19IRCT20200721048159N4Vice Chancellor for Research and Technology of Lorestan University of Medical Sciences100